Results 181 to 190 of about 65,188 (262)

Modulating <i>Bacteroides</i> to boost anti-PD-1 immunotherapy in HCC. [PDF]

J Immunother Cancer
Qi X, Yang M, Liu X, Ma L, Kaifi JT, Ericsson AC, Kimchi ET, Staveley-O'Carroll KF, Li G.   +8 more
europepmc   +1 more source

Phosphorothioate Backbone Modification of Oligodeoxynucleotides Induces TLR9-Independent Lung Epithelial Antimicrobial Responses. [PDF]

Am J Respir Cell Mol Biol
Wang Y, Kulkarni VV, Pantaleón García J, Ntita M, Chavez Cavazos M, Reese TC, Liu Y, Vila Ellis L, Tuvim MJ, Evans SE.   +9 more
europepmc   +1 more source

CpG Oligodeoxynucleotide TLR9 Agonist DV281 [PDF]

, 2020
openaire   +1 more source

Acute Sleep Deprivation and the Autoimmune TLR-BANK1 Pathway: Interplay with Gender and Emotional State. [PDF]

Int J Mol Sci
Ditmer M, Gabryelska A, Tarasiuk-Zawadzka A, Binienda A, Turkiewicz S, Karuga FF, Wojtera A, Białasiewicz P, Fichna J, Strzelecki D, Sochal M.   +10 more
europepmc   +1 more source

Toll-like receptor 9 (TLR9) [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

Circulating Toll-like receptor and cytokine profiles and genetic polymorphisms in a Chinese sepsis cohort: potential links to neuroinflammation and blood-brain barrier dysfunction. [PDF]

Front Immunol
Fan W, Zhao R, Liu J, Luo R, Chen Y.
europepmc   +1 more source

Toll-like receptor 9 (TLR9) [PDF]

Science-Business eXchange, 2014
openaire   +1 more source

Simultaneous detection of lymphocytes and tumor cells <i>in vivo</i> in response to STING-TLR9 immunotherapy with Raman active multiplexed gold nanostars.

Nanoscale Horiz
Kothadiya S, Cutshaw GP, Mathew AP, Zielinski C, Bardhan R.   +4 more
europepmc   +1 more source

Engineering polymeric RNA scaffolds as programmable combinatorial innate immune agonists. [PDF]

Nucleic Acids Res
Yang Y, Alvarez AK, Wang W, Issa ECD, Dorsey E, Wu C.   +5 more
europepmc   +1 more source

TLR9 Agonist DUK-CPG-001 [PDF]

, 2020
openaire   +1 more source